-
Drug Company Profits Set to Increase from Additions to DSM-5 (LLY, NVS, PFE)
Thursday, June 6, 2013 - 8:59am | 612Read More...It’s a simple matter of math. The more diseases there are to treat, the more profit there is to be made – by drug companies that produce the medicines designed to treat those diseases. The Wall Street Journal reported Wednesday that the 5th edition of the Diagnostic and Statistic Manual of...
-
Illumina and Other Bargain Biotech Stocks Worth a Look Now
Wednesday, May 1, 2013 - 12:57pm | 916Read More...The research team at PropThink, which focuses on emerging growth companies in the health care sector, recently offered a list of bargain biotech stocks worth a look. The stocks that made the list include Endo Health Solutions (NASDAQ: ENDP), Illumina (NASDAQ: ILMN) and Keryx Biopharmaceuticals (...
-
Deutsche Bank Updates 6/24
Friday, June 24, 2011 - 8:10am | 504Read More...Deutsche Bank made a number of updates in a research report published today. NASDAQ OMX (NASDAQ: NDAQ) had its rating reiterated at Hold. At the same time, however, its price target was lowered from $30 to $27. On Thursday, NASDAQ lost 2.59% of its value to close the day at $23.35. CBOE Holdings...
